BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

906 related articles for article (PubMed ID: 18005209)

  • 1. Characterization of calcium-independent purinergic receptor-mediated apoptosis in hormone-refractory prostate cancer.
    Shabbir M; Ryten M; Thompson C; Mikhailidis D; Burnstock G
    BJU Int; 2008 Feb; 101(3):352-9. PubMed ID: 18005209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purinergic receptor-mediated effects of ATP in high-grade bladder cancer.
    Shabbir M; Ryten M; Thompson C; Mikhailidis D; Burnstock G
    BJU Int; 2008 Jan; 101(1):106-12. PubMed ID: 17941929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological characterization of P2Y receptor subtypes on isolated tiger salamander Müller cells.
    Reifel Saltzberg JM; Garvey KA; Keirstead SA
    Glia; 2003 Apr; 42(2):149-59. PubMed ID: 12655599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular ATP-induced calcium signaling in mIMCD-3 cells requires both P2X and P2Y purinoceptors.
    Xia SL; Wang L; Cash MN; Teng X; Schwalbe RA; Wingo CS
    Am J Physiol Renal Physiol; 2004 Aug; 287(2):F204-14. PubMed ID: 15068972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increase of intracellular Ca2+ by P2X and P2Y receptor-subtypes in cultured cortical astroglia of the rat.
    Fischer W; Appelt K; Grohmann M; Franke H; Nörenberg W; Illes P
    Neuroscience; 2009 Jun; 160(4):767-83. PubMed ID: 19289154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of firing activity by ATP in dopamine neurons of the rat substantia nigra pars compacta.
    Choi YM; Jang JY; Jang M; Kim SH; Kang YK; Cho H; Chung S; Park MK
    Neuroscience; 2009 May; 160(3):587-95. PubMed ID: 19272429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunocytochemical and pharmacological characterisation of P2-purinoceptor-mediated cell growth and death in PC-3 hormone refractory prostate cancer cells.
    Calvert RC; Shabbir M; Thompson CS; Mikhailidis DP; Morgan RJ; Burnstock G
    Anticancer Res; 2004; 24(5A):2853-9. PubMed ID: 15517888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteoblast responses to nucleotides increase during differentiation.
    Orriss IR; Knight GE; Ranasinghe S; Burnstock G; Arnett TR
    Bone; 2006 Aug; 39(2):300-9. PubMed ID: 16616882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ATP induces intracellular calcium increases and actin cytoskeleton disaggregation via P2x receptors.
    Pubill D; Dayanithi G; Siatka C; Andrés M; Dufour MN; Guillon G; Mendre C
    Cell Calcium; 2001 May; 29(5):299-309. PubMed ID: 11292387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of purine and pyrimidine nucleotides on intracellular Ca2+ in human eosinophils: activation of purinergic P2Y receptors.
    Mohanty JG; Raible DG; McDermott LJ; Pelleg A; Schulman ES
    J Allergy Clin Immunol; 2001 May; 107(5):849-55. PubMed ID: 11344352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct P2Y receptor subtypes regulate calcium signaling in human retinal pigment epithelial cells.
    Tovell VE; Sanderson J
    Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):350-7. PubMed ID: 18172112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of extracellular nucleotides on [Ca2+]i signalling in a human-derived renal proximal tubular cell line (HKC-8).
    Turvey MR; Wang Y; Gu Y
    J Cell Biochem; 2010 Jan; 109(1):132-9. PubMed ID: 19937734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of extracellular nucleotides and nucleosides on prostate carcinoma cells.
    Janssens R; Boeynaems JM
    Br J Pharmacol; 2001 Jan; 132(2):536-46. PubMed ID: 11159704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypotonic stress activates BK channels in clonal kidney cells via purinergic receptors, presumably of the P2Y subtype.
    Hafting T; Haug TM; Ellefsen S; Sand O
    Acta Physiol (Oxf); 2006 Sep; 188(1):21-31. PubMed ID: 16911250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of functional P2X(1) receptors in mouse megakaryocytes.
    Ikeda M
    Thromb Res; 2007; 119(3):343-53. PubMed ID: 16626790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological characterization of heterologously expressed ATP-gated cation channels (P2x purinoceptors).
    Evans RJ; Lewis C; Buell G; Valera S; North RA; Surprenant A
    Mol Pharmacol; 1995 Aug; 48(2):178-83. PubMed ID: 7544432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenine nucleotides inhibit recombinant N-type calcium channels via G protein-coupled mechanisms in HEK 293 cells; involvement of the P2Y13 receptor-type.
    Wirkner K; Schweigel J; Gerevich Z; Franke H; Allgaier C; Barsoumian EL; Draheim H; Illes P
    Br J Pharmacol; 2004 Jan; 141(1):141-51. PubMed ID: 14662731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional distribution of Ca2+-coupled P2 purinergic receptors among adrenergic and noradrenergic bovine adrenal chromaffin cells.
    Tomé AR; Castro E; Santos RM; Rosário LM
    BMC Neurosci; 2007 Jun; 8():39. PubMed ID: 17570839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of functional P2-purinergic receptors in primary cultures of human colorectal carcinoma cells.
    Höpfner M; Lemmer K; Jansen A; Hanski C; Riecken EO; Gavish M; Mann B; Buhr H; Glassmeier G; Scherübl H
    Biochem Biophys Res Commun; 1998 Oct; 251(3):811-7. PubMed ID: 9790992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for multiple P2Y receptors in trabecular meshwork cells.
    Crosson CE; Yates PW; Bhat AN; Mukhin YV; Husain S
    J Pharmacol Exp Ther; 2004 May; 309(2):484-9. PubMed ID: 14742747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.